December 9, 2016

2016: Start Making a Difference. 2017: Take it to the Next Level.

It’s been just over a year since the Adult Vaccine Access Coalition (AVAC) launched on Capitol Hill to raise awareness, improve access, and increase utilization of vaccines among adults. Vaccines protect us from a variety of common diseases that can be serious and even deadly. Here’s a snapshot of our activities over the past year:

July 11, 2016

The Value and Imperative of Quality Measures for Adult Vaccines

Every year, more than 40,000 American adults are hospitalized or die due to vaccine- preventable diseases. In addition, vaccine-preventable diseases cost the U.S. billions each year. As the U.S. population ages at an unprecedented rate, with 78 million Baby Boomers becoming seniors, improving rates of adult vaccination is a national imperative. Higher vaccination rates among adults reduce clinic visits, the rate of hospitalizations, and the incidence of long-term disability. Nevertheless, adult vaccination rates remain far below national targets. A solution to the challenges facing adult vaccination is appropriate vaccine quality measures.

May 25, 2016

AVAC Celebrates Older Americans Month

May is Older Americans Month, a time for honoring and celebrating older adults who have educated us, motivated us, inspired us, and—most importantly—cared for us. Now it’s our chance to redouble our efforts to make sure we care for them. That’s why the Adult Vaccine Access Coalition (AVAC) joined the Administration for Community Living this month to raise awareness about the critical health issues facing older Americans.

March 22, 2016

Vaccines Save Lives

Over 20 years, vaccines will prevent 732,000 deaths and 21 million hospitalizations.

July 29, 2015

Our Best Shot: Expanding Prevention through Vaccination in Older Adults

Our Best Shot: Expanding Prevention through Vaccination in Older Adults, which was authored by Richard Manning, Ph.D., partner, Bates White Economic Consulting, LLC, reviews vaccination levels, trends and targets, incidence rates, relevant health insurance coverage policies, and the cost effectiveness literature and other reports that have evaluated vaccine utilization in the older adult population. It then offers analysis of the …